ACTIVA 37612

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,l report with the FDA on 2020-01-09 for ACTIVA 37612 manufactured by Medtronic Neuromodulation.

Event Text Entries

[174858793] Concomitant medical products: product id: neu_unknown_lead, serial/lot #: unknown. Event country noted as (b)(6), however it is impossible to determine in which country the event occurred. The facilities listed in the article are (b)(6). Age. This value is the average age of the patients reported in the article as specific patients could not be identified. Sex. This value reflects the gender of the majority of the patients reported in the article as specific patients could not be identified. Date of event. Please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature. Danielsson a, carecchio m, cif l, et al. Pallidal deep brain stimulation in dyt6 dystonia: clinical outcome and predictive factors for motor improvement. J clin med. 2019;8(12). 10. 3390/jcm8122163. If information is provided in the future, a supplemental report will be issued. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[174858834] Danielsson a, carecchio m, cif l, et al. Pallidal deep brain stimulation in dyt6 dystonia: clinical outcome and predictive factors for motor improvement. J clin med. 2019;8(12). 10. 3390/jcm8122163. Pallidal deep brain stimulation is an established treatment in dystonia. Available data on the effect in dyt-thap1 dystonia (also known as dyt6 dystonia) are scarce and long-term follow-up studies are lacking. In this retrospective, multicenter follow-up case series of medical records of such patients, the clinical outcome of pallidal deep brain stimulation in dyt-thap1 dystonia, was evaluated. It was determined in one patient that the electrodes and battery were disrupted and when this was discovered and corrected an abdominal wound infection developed which required prolonged antibiotic treatment. The patient subsequently improved. 3 years later the patient had a rapid loss of speech and difficulty swallowing which required a lead replacement. The patient's speech and swallowing returned to normal, however the patient failed to achieve >25% reduction in bfm movement score. In one patient an idiopathic edema along the lead track was discovered. This was later successfully treated with corticosteroids.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007566237-2020-00053
MDR Report Key9570149
Report SourceFOREIGN,HEALTH PROFESSIONAL,L
Date Received2020-01-09
Date of Report2020-01-09
Date of Event2019-12-06
Date Mfgr Received2019-12-19
Date Added to Maude2020-01-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLISA WOODWARD CLARK
Manufacturer Street7000 CENTRAL AVENUE NE RCW215
Manufacturer CityMINNEAPOLIS MN 55432
Manufacturer CountryUS
Manufacturer Postal55432
Manufacturer Phone7635263920
Manufacturer G1MEDTRONIC NEUROMODULATION
Manufacturer Street800 53RD AVE NE
Manufacturer CityMINNEAPOLIS MN 554211200
Manufacturer CountryUS
Manufacturer Postal Code554211200
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameACTIVA
Generic NameIMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)
Product CodeMRU
Date Received2020-01-09
Model Number37612
Catalog Number37612
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC NEUROMODULATION
Manufacturer Address800 53RD AVE NE MINNEAPOLIS MN 554211200 US 554211200


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-01-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.